http://www.arvinas.com
Arvinas, Inc. Company Intro
Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.
Industry
Healthcare
Arvinas, Inc. Headquaters
5 Science Park
New Haven,06511
United States
Arvinas, Inc. Share price
27 Jan 2021 01:08 GMT
$81.45
-1.06 (-1.28 %)
Arvinas, Inc. Market cap
$3.502 B
WMC RANKING
2021
Arvinas, Inc. # 100
BiotechnologyLatest Arvinas, Inc. News
23 Jan 2021
Informative Report On Metastatic Prostate Cancer Treatment ...
Manufacturers Segment Analysis, AB Science, VasGene Therapeutics, Inc., ... Inc.), BeiGene, Zenith Epigenetics Ltd., eFFECTOR Therapeutics, Arvinas Inc., ...
23 Jan 2021
Can You Get A Quick Recovery From Arvinas, Inc. (NASDAQ:ARVN) Given A -10.32% Drop From High?
During the last session, Arvinas, Inc. (NASDAQ:ARVN)'s traded shares were 463,258, with the beta value of the company hitting 0. At the end of the trading day, ...
23 Jan 2021
Informative Report On Metastatic Prostate Cancer Treatment ...
Manufacturers Segment Analysis, AB Science, VasGene Therapeutics, Inc., ... Inc.), BeiGene, Zenith Epigenetics Ltd., eFFECTOR Therapeutics, Arvinas Inc., ...
WMC Market Score
WMC Market to Revenue Score
Arvinas, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Arvinas, Inc. | USD | $24,477 | $128,911 | $-98,833 | $35,020B | 100 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $580,590B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $353,780B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $617,950B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,200B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Arvinas, Inc. Social Followers vs Top 4 Industry Competitors
Arvinas, Inc. Post vs Top 4 Industry Competitors
Arvinas, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Arvinas, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Arvinas, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Arvinas, Inc. | 0.26 | 2.49 | 4.55 | 0 | 0 | 0 | 3.72 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.47 | 10.77 | 100 | 0 | 0 | 93.77 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.60 | 100 | 60 | 0 | 0 | 93.49 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 3.19 | 86 | 0 | 0 | 100 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
